期刊文献+

THP定位诊断早期非肌层浸润性膀胱癌 被引量:4

Feasibility study of early localization diagnosis of THP(pirarubicin) on non-muscle invasive bladder cancer
下载PDF
导出
摘要 目的:研究THP(吡柔比星)对非肌层浸润性膀胱癌早期的定位诊断效果。方法:选择35例已诊断膀胱癌或高度怀疑尿路上皮癌患者。病人术前及术后复查时,30mgTHP溶入50ml 5%葡萄糖液中,灌入已排空的膀胱中,保留15分钟,排出THP,彻底冲洗膀胱。普通膀胱镜检查,有THP吸收的非肿瘤区域取活检,无THP吸收的部位随机活检。结果:35例患者中存在非肌层浸润性膀胱癌早期的共6例。结论:THP对非肌层浸润性膀胱癌早期的定位诊断效果明确,安全性好。 Objective : To study the feasibility of early localization diagnosis of THP (pirarubicin) on non - muscle invasive bladder cancer. Methods : For 35 patients that had the diagnosis of bladder cancer or was highly suspected had carcinoma of urethra epidermis, before or after surgery, integrate 30mg THP into the 50ml 5% glucose,pour the glucose into empty bladder and keep it for 15 minutes,drain and rinse the bladder thoroughly. With normal eystoseo- py, the region with absorption of THP of non - tumor do biopsy and non - absorbed part of THP do random biopsy. Results:In 31 patients, there were 6 had early non -muscle invasive bladder cancer. Conclusion: For non -muscle invasive bladder cancer the early localization diagnosis of THP is clear and safe.
出处 《现代肿瘤医学》 CAS 2011年第2期316-318,共3页 Journal of Modern Oncology
基金 大庆油田总医院集团科研项目(编号:JT0946)
关键词 吡柔比星(THP) 早期非肌层浸润性膀胱癌 定位 pirarubicin (THP) early non - muscle invasive bladder cancer localization
  • 相关文献

参考文献7

二级参考文献38

共引文献182

同被引文献33

  • 1陈从波,王晓康,姚启盛,陈立新,杨勇.经尿道膀胱肿瘤电切术联合经尿道前列腺电汽化术治疗膀胱癌并前列腺增生症[J].中国内镜杂志,2005,11(1):13-14. 被引量:14
  • 2Hart J, Lin T,Xu K,et al.Improved detection of nonmuscle invasive urothelial carcinoma of the bladder using pirarubicin endoscopy: a prospective, single-center preliminary study [J], J Endour01, 2010, 24 (11):1801-1806.
  • 3TakahashiT, Kushiro A, Nomoto K, et al. Antitumor effects of the intravesical itlstillatiorl of beat killed cells of the Lactobacillus casei strain Shirota on the murineorthotopic bladder tumor MBT-2 [J].J Urol, 2001, 166(6):2506-2511.
  • 4Sylvester ILl,van der Meijden AP, Oosterlinck W,et al.Predicting recurrence and progression in individual patients with stage Ta T1 bladder cancer using EORTC risk tables: a combined analysis of 2596 patients from seven EORTC trial[J]. Eur Urol,2006,49(3): 466-467.
  • 5Divrik T,Yildirim U,Eroglu AS,et al.It a second transurethral resection necessary for newly diagnosed pT1 bladder cancer [J].J Urol, 2006,175(22):1258-1261.
  • 6Yumura Y,Takase K,Kato Y,et al.The significance of urine cytology three consecutive days after transurethral resection as a predictor of superficial bladder cancer recurrence[J]. Hinyokika Kiyo, 2004,50(3):171-176.
  • 7Rajala P, Liukkonen T, Raitanen M.et al. Transurethral resection with perioperative instilation on interferon-alpha or epirubicin for the prophylaxis of recurrent primary superficial bladder cancer: a prospective randomized multicenter study-Finnbladder III [J]. J Urol, 1999, 161 (4):1133-1135.
  • 8Mitsumori K, Tsuchiya N,Habuchi T,et al.Early and large-dose intravesical instillation of epirubicin to prevent superficial bladder carcinoma recurrence aider transurethral resection [J]. BJU Int,2004,94 (3): 317-321.
  • 9Oddens JR, vanderMeijden AP, Sylvester R. One immediate postoperative instillation of Chemotherapy in low risk Ta, T1 bladder cancer patients.Isit always safe? [J]. Eur Urol, 2004,46(3): 336-368.
  • 10Eduardo Solsona,Inmaculada Iborra,Argimiro Collado,José Rubio-Briones,Juan Casanova,Ana Calatrava.Feasibility of Radical Transurethral Resection as Monotherapy for Selected Patients With Muscle Invasive Bladder Cancer[J].The Journal of Urology.2010(2)

引证文献4

二级引证文献37

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部